Our research is aimed at seeking new insights into the interplay between active molecules and novel delivery systems; and how this interplay can be maximized to achieve the highest possible therapeutic outcomes. Our research focus utilises nano/micro scale formulation, 3-dimensional printing (3DP) and characterization to address global therapeutic challenges in cancer, diabetes and infection. One of our current projects involves the targeted delivery of the anticancer agent (curcumin), through nano-polymeric formulation.